BankPlus Trust Department Invests $46,000 in Colgate-Palmolive (NYSE:CL)

BankPlus Trust Department bought a new stake in shares of Colgate-Palmolive (NYSE:CLFree Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 501 shares of the company’s stock, valued at approximately $46,000.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Chicago Partners Investment Group LLC grew its holdings in shares of Colgate-Palmolive by 16.2% during the 4th quarter. Chicago Partners Investment Group LLC now owns 6,752 shares of the company’s stock valued at $591,000 after purchasing an additional 943 shares during the last quarter. Peak Financial Advisors LLC bought a new position in shares of Colgate-Palmolive during the 4th quarter valued at $1,315,000. Gordian Advisors LLC bought a new position in shares of Colgate-Palmolive during the 3rd quarter valued at $602,000. Carrera Capital Advisors grew its holdings in shares of Colgate-Palmolive by 23.1% during the 3rd quarter. Carrera Capital Advisors now owns 39,170 shares of the company’s stock valued at $4,066,000 after purchasing an additional 7,353 shares during the last quarter. Finally, Fiduciary Alliance LLC bought a new position in shares of Colgate-Palmolive during the 4th quarter valued at $4,066,000. Institutional investors own 80.41% of the company’s stock.

Analysts Set New Price Targets

CL has been the topic of several recent research reports. Piper Sandler reduced their target price on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a report on Monday, January 6th. Morgan Stanley dropped their price target on shares of Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating for the company in a research report on Monday, February 3rd. TD Cowen dropped their price target on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research report on Wednesday, January 8th. Royal Bank of Canada reissued a “sector perform” rating and set a $101.00 price target on shares of Colgate-Palmolive in a research report on Wednesday, January 29th. Finally, StockNews.com cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Thursday, January 9th. One research analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have given a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $101.16.

Get Our Latest Analysis on Colgate-Palmolive

Colgate-Palmolive Trading Up 2.5 %

Shares of NYSE CL opened at $92.36 on Wednesday. Colgate-Palmolive has a 1 year low of $85.32 and a 1 year high of $109.30. The stock has a market cap of $74.95 billion, a P/E ratio of 26.24, a price-to-earnings-growth ratio of 4.20 and a beta of 0.44. The firm has a 50-day moving average of $88.86 and a 200 day moving average of $95.66. The company has a debt-to-equity ratio of 13.40, a current ratio of 0.92 and a quick ratio of 0.58.

Colgate-Palmolive (NYSE:CLGet Free Report) last issued its quarterly earnings results on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same quarter in the previous year, the company posted $0.87 earnings per share. As a group, sell-side analysts expect that Colgate-Palmolive will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, February 14th. Investors of record on Tuesday, January 21st were given a dividend of $0.50 per share. The ex-dividend date was Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a yield of 2.17%. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 56.82%.

Colgate-Palmolive Company Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Recommended Stories

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.